As part of Health Canada’s initiative to update its approach to regulating self-care products, including non-prescription drugs (broadly, also including cosmetics and natural health products), and as a first step in advance of a regulatory proposal to simplify market access for non-prescription drug products, Health Canada has developed a Non-prescription Drug Action Plan.
The action plan introduces policy and operational solutions to remove barriers for getting non-prescription drugs (excluding ethical drugs, controlled substances, and biocides) to market, by removing repetitious and onerous requirements and introducing flexibilities for industry.
Short-term solutions were announced and effective December 2022, with updates relating to optional subheadings for the Canadian Drug Facts Table, product monograph and patient medication information leaflets, and label mock-up requirements. Medium- and long-term solutions are targeted for the end of 2023 and the end of 2024; Health Canada will publish further information once the work is completed, for example by way of notices.
Should you have any questions, please do not hesitate to contact a member of the Life Sciences Regulatory & Compliance Group.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
New Division 11 of the Food and Drug Regulations: Public or Canadian Armed Forces Health Emergencies - Drugs for Immediate Use or Stockpiling
On February 15, 2023, Regulations Amending Certain Regulations Concerning the Sale of Drugs (Public or Canadian Armed Forces Health Emergencies) came into force.Read More -
Minister of Health announces National Strategy for Drugs for Rare Diseases
On March 22, 2023, the Minister of Health announced the first-ever National Strategy for Drugs for Rare Diseases.Read More -
Permanent regulatory framework for COVID-19 medical devices now in force
On February 22, 2023, amendments to the Medical Devices Regulations came into force that create a permanent regulatory framework for COVID-19 medical devices: Regulations Amending the Medical Devices ...Read More